Happy to share our last work on gene-network analysis predicting clinical response to immunotherapy in NSCLC Stefania Crucitta Diego de Miguel Perez Christian Rolfo sciencedirect.com/science/articl…

ALTA-3 results JTO & JTO CRR: randomized phase III study of 2L alectinib vs brigatinib post crizotinib for #ALK NSCLC. Negative trial - PFS 19.3m with brigatinib, 19.2m with alectinib - but love the head-to-head design and outcomes good in both arms. jto.org/article/S1556-…

Out now on Clinical Cancer Research our commentary on the interesting study of the MD Anderson Cancer Center Funda Meric-Bernstam's group on a novel combination with T-DXd + adavosertib. Thanks to my friends Christian Rolfo and Marzia Del Re, PharmD, PhD! AACR aacrjournals.org/clincancerres/…

Our editorial at Clinical Cancer Research on Adavosertib Enhances Antitumor Activity of Trastuzumab Deruxtecan in HER2-Expressing Cancers by Timothy DiPeri, MD Funda Meric-Bernstam et al MD Anderson Cancer Center Alessandro Russo Marzia Del Re, PharmD, PhD The Tisch Cancer Institute Icahn School of Medicine at Mount Sinai OncoAlert AACR

Welcome in the era where a post has more value than scientific literature evidence.. #sosad

Thanks to the scientific committee of this interesting event for inviting me to presentat on #liquidbiopsy for #BRAF analysis in #CRC 🩸🧬💊 #predictivepharmacology sara lonardi & @matteofassan

Chiusi i lavori della XII Riunione Nazionale Meet-URO Grazie e buone festività a tutti! 🥂🥂

🎄🚨 Exciting Christmas Eve news! Just published in Annals of Oncology ESMO - Eur. Oncology 🎁 Delighted to unwrap our small #PrecisionMedicine present to the scientific & clinical trial community - our latest publication, "Liquid Biopsy Response Evaluation Criteria in Solid Tumors

Excited to share our article in Annals of Oncology about Liquid Biopsy Response Evaluation Criteria in Solid Tumors (LB-RECIST)! MD Anderson Cancer Center International Society of Liquid Biopsy annalsofoncology.org/article/S0923-…

This new editorial explores the epigenetic susceptibility mechanisms of lung cancer through DNA methylation markers: acsjournals.onlinelibrary.wiley.com/doi/10.1002/cn… Christian Rolfo Marzia Del Re, PharmD, PhD Alessandro Russo OncoAlert #LCSM

KRAS G12C inhibition in advanced NSCLC: The new wave of TKIs. Marzia Del Re, PharmD, PhD Christian Rolfo actr.amegroups.org/article/view/8…

Liquid Biopsy (LBx) of Lung Cancer Before Pathological Diagnosis Is Associated With Shorter Time to Treatment. Our analysis of a large database further reinforce the clinical utility of early LBx use in pts with suspected lung cancer. Christian Rolfo Geoff Oxnard MD Lincoln Pasquina

Thanks Rafeh Naqash, MD & JCO Precision Oncology for the kind interview on our paper and great conversation! International Society of Liquid Biopsy The Tisch Cancer Institute Icahn School of Medicine at Mount Sinai Alessandro Russo Marzia Del Re, PharmD, PhD Geoff Oxnard MD Lincoln Pasquina OncoAlert The ASCO Post ASCO

Happening now in Dubai 🧬 Stay tuned 😉 #ifcc #liquidbiopsy

#NewProfilePic

Simposio Satellite-XXVI Congresso Nazionale AIOM 🔸Ottenere il massimo dall’immunoterapia nei tumori solidi Resp. scient.: P. Ascierto, F. Cappuzzo, Marzia Del Re, PharmD, PhD, D. Lorusso, A. Marchetti, S. Novello, P. Queirolo Roma | 9 novembre 2024 Crediti ECM: 0.3 fad.accmed.org/course/info.ph…

ctDNA analysis may be challenging due to tumor shedding variability, leading to false negative results. Happy to share our research aimed at identifying clinical characteristics associated to ctDNA shedding in NSCLC patients. #liquidbiopsy #ctDNA #NSCLC sciencedirect.com/science/articl…

Our paper describing the use of an ultrasensitive circulating tumour DNA detection assay to stratify #TRACERx patients with early-stage non-small cell lung cancer pre-operatively for clinical outcome is out today Nature Medicine. Thread below 👇

Embarking on sth new? Learn from the best. Heartfelt thx to ⁦Sanjay Popat⁩ and his team 4 hosting us @ ⁦The Royal Marsden NHS Foundation Trust⁩ Thrilled to bring the liquid biopsy to Fondazione Policlinico Universitario Gemelli IRCCS!🧬 ⁦⁦Guardant Health⁩ linkedin.com/posts/camilla-…

Common Interactions With Antibiotics